Neurologic Complications of COVID-19 Described
Most common neurologic findings in patients hospitalized for COVID-19 include altered mental status, fatigue, headache, stroke
Most common neurologic findings in patients hospitalized for COVID-19 include altered mental status, fatigue, headache, stroke
The heterogeneous expression of headache associated with COVID-19 indicates various underlying pathophysiological mechanisms.
Matthew Robbins, MD, author of “COVID-19 and headache: a primer for trainees,” details how care has changed for patients with chronic headaches in the midst of the COVID-19 pandemic.
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.
In patients with episodic migraines, the occurrence of a migraine headache does not consistently impact nighttime sleep.
Distinct pattern of abnormal brain connection on fMRI can assist in the differentiation between a healthy brain and a brain with migraine without aura.
Researchers posit that adult studies on headache can help to create a multidisciplinary treatment plan.
Biofeedback may effectively improve headache and urinary incontinence related to prostatectomy.
The main objection among clinical researchers is that commercially developed products often lack a scientific basis for their selection of features.